Dr. Meg Mooney helps coordinate cancer clinical trial networks across the country and internationally, and also organizes initiatives related to innovative cancer treatment reviews and precision medicine. In this episode, Mooney discusses a new natural history study the National Cancer Institute launched for cancer patients with COVID-19, as well as the work being done in drug discovery and development during this time.
HealthCast
Season 1
Episode 10
18m listen
Dr. Meg Mooney, Associate Director of CTEP, NCI
Share
The office coordinates nationwide testing of new treatment approaches for cancer.
-
Meg Mooney Associate Director of CTEP NCI
Related Content
-
CISA CIO on Agentic AI, Building the Cyber Workforce
Bob Costello discusses deploying agentic AI, speeding cyber approvals and strengthening the federal cybersecurity talent pipeline.
9m watch -
A New Era of Open-Source Geospatial Collaboration
Former NGA official Will Mortenson shares his journey from 27 years of government service to leading a global mapping revolution at the Overture Maps Foundation.
7m watch -
AI Demands Secure, Expanded Data Infrastructure
Growing AI workloads are forcing agencies to rethink storage, cybersecurity and infrastructure investments to support innovation.
5m watch -
Flipping the Script on AI Adoption at Space Force
The newest military service is moving away from off-the-shelf solutions to build a culture of internal innovation and mission-specific tools.
10m watch
